In silico study of alkaloids with quercetin nucleus for inhibition of SARS-CoV-2 protease and receptor cell protease

In silico study of alkaloids with quercetin nucleus for inhibition of SARS-CoV-2 protease and receptor cell protease

Bibliographic Details
Main Authors:	Ali Mohebbi, Marzieh Eskandarzadeh, Hanieh Zangi, Marzie Fatehi
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11020608/?tool=EBI

Similar Items

In silico exploration of Lycoris alkaloids as potential inhibitors of SARS-CoV-2 main protease (Mpro)
by: Fredrick Mutie Musila, et al.
Published: (2022-09-01)

In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2
by: Kunal Bhattacharya, et al.
Published: (2022-03-01)

In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2
by: Mohibullah Shah, et al.
Published: (2024-01-01)

In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2.
by: Mohibullah Shah, et al.
Published: (2024-01-01)

In-silico approaches for identification of compounds inhibiting SARS-CoV-2 3CL protease.
by: Md Zeyaullah, et al.
Published: (2023-01-01)

In Silico Activity Identification of Cyclo Peptide Alkaloids from Zizyphus Spina-Christi Species Against Sars-Cov-2 Main Protease
by: Taufik Muhammad Fakih, et al.
Published: (2021-06-01)

In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus
by: Phaedra Eleftheriou, et al.
Published: (2020-05-01)

Plant-derived compounds effectively inhibit the main protease of SARS-CoV-2: An in silico approach.
by: Shafi Mahmud, et al.
Published: (2022-01-01)

Plant-derived compounds effectively inhibit the main protease of SARS-CoV-2: An in silico approach
by: Shafi Mahmud, et al.
Published: (2022-01-01)

In silico Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease
by: Tien Huynh, et al.
Published: (2021-02-01)

Mechanistic Insights into the Inhibition of SARS-CoV-2 Main Protease by Clovamide and Its Derivatives: In Silico Studies
by: Naike Ye, et al.
Published: (2021-09-01)

In silico screening of antiviral compounds from Moringa oleifera for inhibition of SARS-CoV-2 main protease
by: Bala Mohan Sivani, et al.
Published: (2021-01-01)

In Silico Study of Mangrove Triterpenoids as SARS-CoV-2 Main Protease Inhibitors
by: Ramamoorthy Purushothaman, et al.
Published: (2023-06-01)

Inhibition of enterovirus 71 replication and viral 3C protease by quercetin
by: Chenguang Yao, et al.
Published: (2018-07-01)

Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease
by: Qian Wang, et al.
Published: (2023-02-01)

SARS-CoV-2 Papain-Like Protease Potential Inhibitors—In Silico Quantitative Assessment
by: Adam Stasiulewicz, et al.
Published: (2021-04-01)

Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study
by: Rajveer Singh, et al.
Published: (2020-10-01)

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
by: Menghan Gao, et al.
Published: (2023-07-01)

In Silico Testing of Some Protected Galactopyranose as SARS-CoV-2 Main Protease Inhibitors
by: Abul K.M.S. Azad, et al.
Published: (2022-10-01)

Natural compounds as potential inhibitors of SARS-CoV-2 main protease: An in-silico study
by: Amaresh Mishra, et al.
Published: (2021-01-01)

2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies
by: Pandu Hariyono, et al.
Published: (2022-01-01)

In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
by: Baby Krishnaprasad, et al.
Published: (2020-11-01)

Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications
by: Oisin F. McElvaney, et al.
Published: (2022-03-01)

In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants
by: Haruna I. Umar, HND, et al.
Published: (2021-04-01)

In silico studies of selected xanthophylls as potential candidates against SARS-CoV-2 targeting main protease (Mpro) and papain-like protease (PLpro)
by: Karpiński Tomasz M., et al.
Published: (2021-06-01)

An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition
by: Gabriela Dias Noske, et al.
Published: (2023-03-01)

Cotton flower metabolites inhibit SARS‐CoV‐2 main protease
by: Yufang Zhang, et al.
Published: (2022-10-01)

Inhibition of the 3CL Protease and SARS-CoV‑2 Replication by Dalcetrapib
by: Eric J Niesor, et al.
Published: (2021-06-01)

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
by: Mohamed Mahdi, et al.
Published: (2020-11-01)

Molecular Docking Study of Nigella sativa Alkaloid Compounds as the Inhibitor of Papain-Like Protease SARS-CoV-2
by: Gusnia Meilin Gholam, et al.
Published: (2023-06-01)

In silico Screening of Potential SARS-CoV-2 Main Protease Inhibitors from Thymus schimperi
by: Mengist HM, et al.
Published: (2023-01-01)

Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking
by: Tamer M. Ibrahim, et al.
Published: (2020-11-01)

In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis
by: Azza Hanif Harisna, et al.
Published: (2021-07-01)

In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease
by: Osvaldo Yañez, et al.
Published: (2021-02-01)

In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2
by: Abdullah G. Al-Sehemi, et al.
Published: (2022-05-01)

Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease
by: Lukas van de Sand, et al.
Published: (2021-04-01)

Inhibition of the SARS-CoV-2 Main Protease by Isoquercitrin γ-Cyclodextrin Inclusion Complex Formulations: A Biochemical and In Silico Study
by: Martin Wurtele, et al.
Published: (2023-01-01)

In silico screening, SAR and kinetic studies of naturally occurring flavonoids against SARS CoV-2 main protease
by: Muhammad Imran, et al.
Published: (2022-01-01)

In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2
by: Seyyed Sasan Mousavi, et al.
Published: (2021-09-01)

Plant flavonoid inhibition of SARS-CoV-2 main protease and viral replication
by: Lin Lin, et al.
Published: (2023-09-01)